CLNC yields 36.68% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CLNC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLNC + PFE for your $10,000?
Colony Credit Real Estate, Inc. operates as a real estate investment trust. The company is headquartered in Los Angeles, California. The company is focused on originating and acquiring a diversified portfolio of CRE debt and net lease real estate investments. Its diversified portfolio consists of senior mortgage loans, mezzanine loans, preferred equity, CRE debt securities and net leased properties. The company operates through four segments: Commercial Real Estate Debt, which is focused on originating, acquiring and asset managing CRE debt investments, including mortgage loans, subordinate interests and mezzanine loans, as well as preferred equity interests; Commercial Real Estate Equity, which is focused on the ownership in real estate and real estate assets, and Commercial Real Estate Securities, which is focused on investing in commercial mortgage-backed securities, unsecured REIT debt, collateralized debt obligation (CDO) notes and other securities.
Full CLNC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.